All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
(Image credit: Visoot Uthairam/Moment RF)
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.(Image credit: Visoot Uthairam/Moment RF)
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
(Image credit: Visoot Uthairam/Moment RF)